Inventor · disambiguated record
Adam D. Hughes
Also filed as: HUGHES ADAM · HUGHES ADAM D
136 granted patents·11 pending applications·1,622 citations·filing 2003–2024
99Inventor score
Files withTHERAVANCE BIOPHARMA R&D IP LLC59THERAVANCE INC32FLEURY MELISSA11THERAVANCE RESPIRATORY CO LLC10HUGHES ADAM D9
Top patents by PatentIndex Score
147 records- 0198US9126956B2Neprilysin inhibitorsFLEURY MELISSA·Filed 2013·Granted Sep 8, 2015·51 cites·43 claims
- 0298US9108934B2Neprilysin inhibitorsHUGHES ADAM D·Filed 2013·Granted Aug 18, 2015·51 cites·28 claims
- 0398US8871792B2Neprilysin inhibitorsHUGHES ADAM D·Filed 2013·Granted Oct 28, 2014·53 cites·24 claims
- 0498US8691868B2Neprilysin inhibitorsHUGHES ADAM D·Filed 2012·Granted Apr 8, 2014·57 cites·31 claims
- 0598US8586536B2Neprilysin inhibitorsGENDRON ROLAND·Filed 2011·Granted Nov 19, 2013·72 cites·26 claims
- 0698US8513244B2Neprilysin inhibitorsGENDRON ROLAND·Filed 2012·Granted Aug 20, 2013·79 cites·20 claims
- 0798US8481044B2Neprilysin inhibitorsFLEURY MELISSA·Filed 2012·Granted Jul 9, 2013·67 cites·29 claims
- 0897US9045443B2Nitric oxide donor neprilysin inhibitorsMAMMEN MATHAI·Filed 2013·Granted Jun 2, 2015·53 cites·22 claims
- 0997US8449890B2Neprilysin inhibitorsFLEURY MELISSA·Filed 2012·Granted May 28, 2013·68 cites·26 claims
- 1097US7524965B2Dialkylphenyl compounds having β2 adrenergic receptor agonist and muscarinic receptor antagonist activityTHERAVANCE INC·Filed 2007·Granted Apr 28, 2009·44 cites·10 claims
- 1196US8686184B2Neprilysin inhibitorsFLEURY MELISSA·Filed 2012·Granted Apr 1, 2014·61 cites·25 claims
- 1296US8563512B2Neprilysin inhibitorsSMITH CAMERON·Filed 2011·Granted Oct 22, 2013·62 cites·22 claims
- 1396US7524959B2Biphenyl derivativesTHERAVANCE INC·Filed 2006·Granted Apr 28, 2009·36 cites·19 claims
- 1496US7521561B2Biphenyl derivativesTHERAVANCE INC·Filed 2006·Granted Apr 21, 2009·36 cites·19 claims
- 1596US7514558B2Biphenyl derivativesTHERAVANCE INC·Filed 2006·Granted Apr 7, 2009·32 cites·18 claims
- 1696US7355046B2Biphenyl derivativesTHERAVANCE INC·Filed 2006·Granted Apr 8, 2008·42 cites·17 claims
- 1796US7345175B2Biphenyl derivativesTHERAVANCE INC·Filed 2006·Granted Mar 18, 2008·49 cites·17 claims
- 1896US7141671B2Biphenyl derivativesTHERAVANCE INC·Filed 2004·Granted Nov 28, 2006·145 cites·42 claims
- 1995US9873685B2Neprilysin inhibitorsTHERAVANCE BIOPHARMA R&D IP LLC·Filed 2017·Granted Jan 23, 2018·10 cites·7 claims
- 2095US9670186B2Neprilysin inhibitorsFLEURY MELISSA·Filed 2015·Granted Jun 6, 2017·12 cites·7 claims
- 2195US7507751B2Biphenyl derivativesTHERAVANCE INC·Filed 2007·Granted Mar 24, 2009·33 cites·21 claims
- 2294US10759813B2Neprilysin inhibitorsTHERAVANCE BIOPHARMA R&D IP LLC·Filed 2019·Granted Sep 1, 2020·3 cites·18 claims
- 2394US10189823B2Neprilysin inhibitorsTHERAVANCE BIOPHARMA R&D IP LLC·Filed 2017·Granted Jan 29, 2019·9 cites·3 claims
- 2494US9845332B2Neprilysin inhibitorsTHERAVANCE BIOPHARMA R&D IP LLC·Filed 2017·Granted Dec 19, 2017·7 cites·1 claims
- 2594US9120747B2Neprilysin inhibitorsGENDRON ROLAND·Filed 2013·Granted Sep 1, 2015·16 cites·16 claims
- 2694US8846913B2Neprilysin inhibitorsTHERAVANCE INC·Filed 2013·Granted Sep 30, 2014·18 cites·10 claims
- 2794US7879879B2Biphenyl derivativesTHERAVANCE INC·Filed 2006·Granted Feb 1, 2011·19 cites·7 claims
- 2894US7687521B2Dialkylphenyl compounds having beta2 adrenergic receptor agonist and muscarinic receptor antagonist activityTHERAVANCE INC·Filed 2009·Granted Mar 30, 2010·23 cites·11 claims
- 2993US11230536B2Crystalline (2S,4R)-5-(5′-chloro-2′-fluoro-[1,1′-biphenyl]-4-yl)-2-(ethoxymethyl)-4-(3-hydroxyisoxazole-5-carboxamido)-2-methylpentanoic acid and uses thereofTHERAVANCE BIOPHARMA R&D IP LLC·Filed 2020·Granted Jan 25, 2022·2 cites·20 claims
- 3093US7829583B2Biphenyl derivativesTHERAVANCE INC·Filed 2007·Granted Nov 9, 2010·15 cites·21 claims
- 3193US7524880B2Crystalline form of a substituted pyrrolidine compoundTHERAVANCE INC·Filed 2005·Granted Apr 28, 2009·23 cites·13 claims
- 3292US11124502B2Neprilysin inhibitorsTHERAVANCE BIOPHARMA R&D IP LLC·Filed 2020·Granted Sep 21, 2021·2 cites·20 claims
- 3392US10570120B2Neprilysin inhibitorsTHERAVANCE BIOPHARMA R&D IP LLC·Filed 2018·Granted Feb 25, 2020·6 cites·20 claims
- 3492US10336773B2Neprilysin inhibitorsTHERAVANCE BIOPHARMA R&D IP LLC·Filed 2017·Granted Jul 2, 2019·5 cites·6 claims
- 3592US9688692B2Neprilysin inhibitorsTHERAVANCE BIOPHARMA R&D IP LLC·Filed 2016·Granted Jun 27, 2017·7 cites·11 claims
- 3692US9394275B2Diamide compounds having muscarinic receptor antagonist and BETA2 adrenergic receptor agonist activityTHERAVANCE RESPIRATORY CO LLC·Filed 2015·Granted Jul 19, 2016·7 cites·11 claims
- 3792US9388145B2Neprilysin inhibitorsGENDRON ROLAND·Filed 2015·Granted Jul 12, 2016·8 cites·9 claims
- 3892US8901169B2Neprilysin inhibitorsFENSTER ERIK·Filed 2014·Granted Dec 2, 2014·14 cites·31 claims
- 3992US7728144B2Biphenyl compounds useful as muscarinic receptor antagonistsTHERAVANCE INC·Filed 2006·Granted Jun 1, 2010·20 cites·17 claims
- 4091US9682957B2Diamide compounds having muscarinic receptor antagonist and β2 adrenergic receptor agonist activityTHERAVANCE RESPIRATORY CO LLC·Filed 2016·Granted Jun 20, 2017·5 cites·2 claims
- 4191US9572802B2Diamide compounds having muscarinic receptor antagonist and β2 adrenergic receptor agonist activityTHERAVANCE RESPIRATORY CO LLC·Filed 2016·Granted Feb 21, 2017·5 cites·30 claims
- 4291US9533962B2(2R,4R)-5-(5′-chloro-2′-fluorobiphenyl-4-yl)-2-hydroxy-4-[(5-methyloxazole-2-carbonyl)amino]pentanoic acidTHERAVANCE BIOPHARMA R&D IP LLC·Filed 2016·Granted Jan 3, 2017·6 cites·28 claims
- 4391US9000173B2Diamide compounds having muscarinic receptor antagonist and β2 adrenergic receptor agonist activityHUGHES ADAM D·Filed 2014·Granted Apr 7, 2015·7 cites·5 claims
- 4491US8816088B2Diamide compounds having muscarinic receptor antagonist and β2 adrenergic receptor agonist activityTHERAVANCE INC·Filed 2013·Granted Aug 26, 2014·7 cites·1 claims
- 4591US8138345B2Diamide compounds having muscarinic receptor antagonist and β2 adrenergic receptor agonist activityHUGHES ADAM·Filed 2010·Granted Mar 20, 2012·13 cites·3 claims
- 4691US8134006B2Dialkylphenyl compounds having β2 adrenergic receptor agonist and muscarinic receptor antagonist activityCOLSON PIERRE-JEAN·Filed 2010·Granted Mar 13, 2012·15 cites·8 claims
- 4791US7569586B2Compounds having β2 adrenergic receptor agonist and muscarinic receptor antagonist activityTHERAVANCE INC·Filed 2005·Granted Aug 4, 2009·23 cites·35 claims
- 4890US10744104B2Neprilysin inhibitorsTHERAVANCE BIOPHARMA R&D IP LLC·Filed 2018·Granted Aug 18, 2020·2 cites·20 claims
- 4990US9975875B2Diamide compounds having muscarinic receptor antagonist and Beta2 adrenergic receptor agonist activityTHERAVANCE RESPIRATORY CO LLC·Filed 2017·Granted May 22, 2018·4 cites·3 claims
- 5090US9499487B2Neprilysin inhibitorsFLEURY MELISSA·Filed 2012·Granted Nov 22, 2016·12 cites·10 claims
Showing the top 50 of 147 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →